Company Filing History:
Years Active: 2017-2020
Title: The Innovative Contributions of Aaron Moulin
Introduction
Aaron Moulin is a notable inventor based in Ashland, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of engineered antibodies. With a total of 2 patents, his work focuses on advancing therapeutic options for various medical conditions.
Latest Patents
Moulin's latest patents include the development of engineered anti-TGF-β antibodies and antigen-binding fragments. These antibodies are designed to bind Transforming Growth Factor-β (TGF-β) with isoform selectivity. Specifically, they may selectively bind human TGF-β1 compared to human TGF-β2 and TGF-β3, or vice versa. The design of these antibodies is supported by co-crystal structures of recombinant Fab fragments and scFv versions bound to TGF-β isoforms.
Career Highlights
Aaron Moulin is currently employed at Genzyme Corporation, a leading biotechnology company. His work at Genzyme has allowed him to focus on innovative solutions in the field of therapeutic antibodies. His contributions have been instrumental in advancing the understanding and application of TGF-β in medical treatments.
Collaborations
Moulin collaborates with talented professionals such as Ronnie Rong Wei and Magali Mathieu. These collaborations enhance the research and development efforts at Genzyme Corporation, fostering an environment of innovation and discovery.
Conclusion
Aaron Moulin's work exemplifies the spirit of innovation in biotechnology. His patents and collaborations contribute to the advancement of medical science, particularly in the area of engineered antibodies. His efforts continue to pave the way for new therapeutic options in healthcare.